Biotage AB
STO:BIOT
Biotage AB
STO:BIOT
Price:
178.4 SEK
-3.78%
Updated:
Jun 3, 2024
Biotage AB
Cash from Financing Activities
|
Biotage AB
Cash from Financing Activities Peer Comparison
Comparables:
OLK
ALIF B
BICO
MCAP
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biotage AB
STO:BIOT
|
Cash from Financing Activities
-kr142m
|
CAGR 3-Years
-85%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-6%
|
|
|
Olink Holding AB (publ)
NASDAQ:OLK
|
Cash from Financing Activities
$92.5m
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AddLife AB
STO:ALIF B
|
Cash from Financing Activities
-kr554m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Cash from Financing Activities
-kr102m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MedCap AB (publ)
STO:MCAP
|
Cash from Financing Activities
-kr66.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
-66%
|
See Also
What is Biotage AB's Cash from Financing Activities?
Cash from Financing Activities
-142m
SEK
-142m
SEK
Based on the financial report for Mar 31, 2024, Biotage AB's Cash from Financing Activities amounts to -142m SEK.
What is Biotage AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-6%
-6%
Over the last year, the Cash from Financing Activities growth was -6%. The average annual Cash from Financing Activities growth rates for Biotage AB have been -85% over the past three years , -10% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
